These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28261087)

  • 1. Mechanism of Action of Prolyl Oligopeptidase (PREP) in Degenerative Brain Diseases: Has Peptidase Activity Only a Modulatory Role on the Interactions of PREP with Proteins?
    Männistö PT; García-Horsman JA
    Front Aging Neurosci; 2017; 9():27. PubMed ID: 28261087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolyl oligopeptidase and dipeptidyl peptidase II/dipeptidyl peptidase IV ratio in the cerebrospinal fluid in Parkinson's disease: historical overview and future prospects.
    Nagatsu T
    J Neural Transm (Vienna); 2017 Jun; 124(6):739-744. PubMed ID: 27503084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four day inhibition of prolyl oligopeptidase causes significant changes in the peptidome of rat brain, liver and kidney.
    Tenorio-Laranga J; Männistö PT; Storvik M; Van der Veken P; García-Horsman JA
    Biochimie; 2012 Sep; 94(9):1849-59. PubMed ID: 22546504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular prolyl oligopeptidase derived from activated microglia is a potential neuroprotection target.
    Natunen TA; Gynther M; Rostalski H; Jaako K; Jalkanen AJ
    Basic Clin Pharmacol Toxicol; 2019 Jan; 124(1):40-49. PubMed ID: 29998529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Prolyl Oligopeptidase Restores Spontaneous Motor Behavior in the α-Synuclein Virus Vector-Based Parkinson's Disease Mouse Model by Decreasing α-Synuclein Oligomeric Species in Mouse Brain.
    Svarcbahs R; Julku UH; Myöhänen TT
    J Neurosci; 2016 Dec; 36(49):12485-12497. PubMed ID: 27927963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolyl oligopeptidase: a rising star on the stage of neuroinflammation research.
    Penttinen A; Tenorio-Laranga J; Siikanen A; Morawski M; Rossner S; García-Horsman JA
    CNS Neurol Disord Drug Targets; 2011 May; 10(3):340-8. PubMed ID: 21222623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of prolyl oligopeptidase in mice disturbs synaptic plasticity and reduces anxiety-like behaviour, body weight, and brain volume.
    Höfling C; Kulesskaya N; Jaako K; Peltonen I; Männistö PT; Nurmi A; Vartiainen N; Morawski M; Zharkovsky A; Võikar V; Roßner S; García-Horsman JA
    Eur Neuropsychopharmacol; 2016 Jun; 26(6):1048-61. PubMed ID: 26996375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New tricks of prolyl oligopeptidase inhibitors - A common drug therapy for several neurodegenerative diseases.
    Svarcbahs R; Julku U; Kilpeläinen T; Kyyrö M; Jäntti M; Myöhänen TT
    Biochem Pharmacol; 2019 Mar; 161():113-120. PubMed ID: 30660495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ prolyl oligopeptidase activity assay in neural cell cultures.
    Klimaviciusa L; Jain RK; Jaako K; Van Elzen R; Gerard M; van Der Veken P; Lambeir AM; Zharkovsky A
    J Neurosci Methods; 2012 Feb; 204(1):104-110. PubMed ID: 22101193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development and validation of a combined kinetic fluorometric activity assay for fibroblast activation protein alpha and prolyl oligopeptidase in plasma.
    Bracke A; Van Elzen R; Van Der Veken P; Augustyns K; De Meester I; Lambeir AM
    Clin Chim Acta; 2019 Aug; 495():154-160. PubMed ID: 30981844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of prolyl oligopeptidase by KYP-2047 fails to increase the extracellular neurotensin and substance P levels in rat striatum.
    Jalkanen AJ; Savolainen K; Forsberg MM
    Neurosci Lett; 2011 Sep; 502(2):107-11. PubMed ID: 21820035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson's and Alzheimer's diseases.
    Hannula MJ; Myöhänen TT; Tenorio-Laranga J; Männistö PT; Garcia-Horsman JA
    Neuroscience; 2013 Jul; 242():140-50. PubMed ID: 23562579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KYP-2047 penetrates mouse brain and effectively inhibits mouse prolyl oligopeptidase.
    Jalkanen AJ; Leikas JV; Forsberg MM
    Basic Clin Pharmacol Toxicol; 2014 Jun; 114(6):460-3. PubMed ID: 24350801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression levels of prolyl oligopeptidase responds not only to neuroinflammation but also to systemic inflammation upon liver failure in rat models and cirrhotic patients.
    Tenorio-Laranga J; Montoliu C; Urios A; Hernandez-Rabaza V; Ahabrach H; García-Horsman JA; Felipo V
    J Neuroinflammation; 2015 Sep; 12():183. PubMed ID: 26420028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dynamics, crystallography and mutagenesis studies on the substrate gating mechanism of prolyl oligopeptidase.
    Kaszuba K; Róg T; Danne R; Canning P; Fülöp V; Juhász T; Szeltner Z; St Pierre JF; García-Horsman A; Männistö PT; Karttunen M; Hokkanen J; Bunker A
    Biochimie; 2012 Jun; 94(6):1398-411. PubMed ID: 22484394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of prolyl oligopeptidase in human peripheral tissues and in ovarian and colorectal tumors.
    Myöhänen TT; Pyykkö E; Männistö PT; Carpen O
    J Histochem Cytochem; 2012 Sep; 60(9):706-15. PubMed ID: 22740343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the role of prolyl oligopeptidase in health and disease.
    García-Horsman JA; Männistö PT; Venäläinen JI
    Neuropeptides; 2007 Feb; 41(1):1-24. PubMed ID: 17196652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolyl oligopeptidase is a glyceraldehyde-3-phosphate dehydrogenase-binding protein that regulates genotoxic stress-induced cell death.
    Matsuda T; Sakaguchi M; Tanaka S; Yoshimoto T; Takaoka M
    Int J Biochem Cell Biol; 2013 Apr; 45(4):850-7. PubMed ID: 23348613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse prolyl oligopeptidase plays a role in trophoblast stem cell differentiation into trophoblast giant cell and spongiotrophoblast.
    Maruyama Y; Matsubara S; Kimura AP
    Placenta; 2017 May; 53():8-15. PubMed ID: 28487025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of peptide-based prolyl oligopeptidase inhibitors--introduction of N-benzyloxycarbonyl-prolyl-3-fluoropyrrolidine as a lead in inhibitor design.
    Goossens F; Vanhoof G; De Meester I; Augustyns K; Borloo M; Tourwe D; Haemers A; Scharpé S
    Eur J Biochem; 1997 Nov; 250(1):177-83. PubMed ID: 9432007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.